SPARK Trial
Cross-source consensus on SPARK Trial from 1 sources and 6 claims.
1 sources · 6 claims
Comparisons
Other
Other
Other
Highlighted claims
- The SPARK trial is a 6-month multicentre randomised controlled superiority trial with a pragmatic design. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
- The primary outcome is inactive disease at 12 weeks, defined by ASDAS below 1.3. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
- The trial compares remote personalised exercise with treatment as usual during the first 12 weeks. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
- After 12 weeks, all participants are rerandomised so each receives SPARK for at least 3 months. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
- The main analysis will use the intention-to-treat principle. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial
- The planned sample size is 260 participants with equal baseline allocation to usual care and SPARK. — Remote personalised exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomised controlled trial